title: Evaluation of the feasibility of a state-based vaccine safety advice network.
abstract: The vaccine safety advice network is a collaborative pilot project between Vanderbilt University Medical Center, the Tennessee Department of Health, and the Centers for Disease Control and Prevention to assess the feasibility of addressing vaccine safety questions posed by healthcare providers in near real-time. Using a two-tier response system and an electronic database for query submission, the pilot project received ten queries in three and one half months. Two of three pre-specified benchmarks for program evaluation, addressing queries within 24 h of receipt and 100% provider satisfaction, were met; one benchmark, the percentage of questions addressed by Tier 1 staff, was not met. Limitations included few submitted queries primarily involving children in the pilot period, "after-only" program evaluation, and limited geographic generalizability. The study demonstrates a successful partnership between federal, state and academic institutions and a feasible method to respond to healthcare provider inquiries about vaccine safety in near real-time.
authors.affiliation: Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children's Way, Suite 2404, Nashville, TN, United States; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, 21st Avenue South CCC 5311 MCN, Nashville, TN 37232, United States. Electronic address: elizabeth.williams@vanderbilt.edu.
authors.forename: S Elizabeth
authors.initials: SE
authors.lastname: Williams
authors.affiliation: Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, United States.
authors.forename: Claudia
authors.initials: C
authors.lastname: Vellozzi
authors.affiliation: Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children's Way, Suite 2404, Nashville, TN, United States; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, 21st Avenue South CCC 5311 MCN, Nashville, TN 37232, United States.
authors.forename: Kathryn M
authors.initials: KM
authors.lastname: Edwards
authors.affiliation: Tennessee Immunization Program, Tennessee Department of Health, 710 James Robertson Parkway, Andrew Johnson Tower, 3rd Floor, Nashville, TN 37243, United States.
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Moore
authors.affiliation: Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, United States.
authors.forename: Devindra
authors.initials: D
authors.lastname: Sharma
authors.affiliation: Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children's Way, Suite 2404, Nashville, TN, United States; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, 21st Avenue South CCC 5311 MCN, Nashville, TN 37232, United States.
authors.forename: Clarence B
authors.initials: CB
authors.lastname: Creech
mesh_terms: D019985:Benchmarking; D002487:Centers for Disease Control and Prevention, U.S.; D016208:Databases, Factual; D005240:Feasibility Studies; D033181:Information Dissemination; D007255:Information Services; D020407:Internet; D010865:Pilot Projects; D013714:Tennessee; D014481:United States; D014611:Vaccination / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines
keywords: Adverse events following immunization; Vaccine safety